MedTrace Logo

UroX Biomarker Bladder Cancer Study

NCT03973307 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2019-06-04

No results posted yet for this study

Summary

This is a prospective observational study looking at urine samples from participants under referral for a standard of care investigative cystoscopy and biopsy.

The study aims to test if the UroX™ biomarker (a measurable indicator of a biological condition) can be detected in urine samples from participants who may later test positive following a biopsy for bladder cancer. The study aims to assess the value of the biomarker as a screening tool for bladder cancer.

Patients with and those without bladder cancer are required for the study.

Conditions

Interventions

DIAGNOSTIC_TEST

UroX bladder cancer biomarker test

Urine test using novel UroX biomarker test for bladder malignancy

Sponsors & Collaborators

  • KDx Diagnostics Inc.

    collaborator UNKNOWN

  • East and North Hertfordshire NHS Trust

    lead OTHER_GOV

Principal Investigators

  • Nikhil Vasdev · East and North Hertfordshire NHS Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-21
Primary Completion
2020-07-01
Completion
2025-07-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03973307 on ClinicalTrials.gov